Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3745962rdf:typepubmed:Citationlld:pubmed
pubmed-article:3745962lifeskim:mentionsumls-concept:C0010453lld:lifeskim
pubmed-article:3745962lifeskim:mentionsumls-concept:C1513095lld:lifeskim
pubmed-article:3745962lifeskim:mentionsumls-concept:C0332157lld:lifeskim
pubmed-article:3745962lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:3745962lifeskim:mentionsumls-concept:C0052761lld:lifeskim
pubmed-article:3745962lifeskim:mentionsumls-concept:C0087163lld:lifeskim
pubmed-article:3745962lifeskim:mentionsumls-concept:C0591833lld:lifeskim
pubmed-article:3745962pubmed:issue4lld:pubmed
pubmed-article:3745962pubmed:dateCreated1986-10-15lld:pubmed
pubmed-article:3745962pubmed:abstractTextThe cytotoxic effect of azelaic acid on murine melanoma cells in culture is due, at least in part, to an antimitochondrial action. We investigated the possibility that the addition of carnitine to the medium may increase the transport of azelaic acid into the mitochondria and thereby increase its cytotoxic effect. Using mitochondrial cross-sectional area measured from electron micrographs as a criterion for mitochondrial damage, we found that the addition of L-carnitine to the culture medium had no effect either alone or with a low (10(-3) M) concentration of azelaic acid. At a high concentration (5 X 10(-2) M) azelaic acid caused swelling and disruption of the mitochondria to such an extent that this was not increased by carnitine. At 10(-2) M azelaic acid, however, some swelling of the mitochondria occurred which was significantly increased by the addition of carnitine. This indicates that carnitine-mediated transport of the diacid into the mitochondria had occurred. We conclude that carnitine may reduce the time or concentration needed for azelaic acid to have a toxic effect on the malignant melanocyte.lld:pubmed
pubmed-article:3745962pubmed:languageenglld:pubmed
pubmed-article:3745962pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3745962pubmed:citationSubsetIMlld:pubmed
pubmed-article:3745962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3745962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3745962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3745962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3745962pubmed:statusMEDLINElld:pubmed
pubmed-article:3745962pubmed:monthAprlld:pubmed
pubmed-article:3745962pubmed:issn0022-202Xlld:pubmed
pubmed-article:3745962pubmed:authorpubmed-author:BreathnachA...lld:pubmed
pubmed-article:3745962pubmed:authorpubmed-author:PassiSSlld:pubmed
pubmed-article:3745962pubmed:authorpubmed-author:Nazzaro-Porro...lld:pubmed
pubmed-article:3745962pubmed:authorpubmed-author:WardB JBJlld:pubmed
pubmed-article:3745962pubmed:authorpubmed-author:EthridgeLLlld:pubmed
pubmed-article:3745962pubmed:authorpubmed-author:RobinsE JEJlld:pubmed
pubmed-article:3745962pubmed:authorpubmed-author:BhasinY PYPlld:pubmed
pubmed-article:3745962pubmed:issnTypePrintlld:pubmed
pubmed-article:3745962pubmed:volume86lld:pubmed
pubmed-article:3745962pubmed:ownerNLMlld:pubmed
pubmed-article:3745962pubmed:authorsCompleteYlld:pubmed
pubmed-article:3745962pubmed:pagination438-41lld:pubmed
pubmed-article:3745962pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3745962pubmed:meshHeadingpubmed-meshheading:3745962-...lld:pubmed
pubmed-article:3745962pubmed:meshHeadingpubmed-meshheading:3745962-...lld:pubmed
pubmed-article:3745962pubmed:meshHeadingpubmed-meshheading:3745962-...lld:pubmed
pubmed-article:3745962pubmed:meshHeadingpubmed-meshheading:3745962-...lld:pubmed
pubmed-article:3745962pubmed:meshHeadingpubmed-meshheading:3745962-...lld:pubmed
pubmed-article:3745962pubmed:meshHeadingpubmed-meshheading:3745962-...lld:pubmed
pubmed-article:3745962pubmed:meshHeadingpubmed-meshheading:3745962-...lld:pubmed
pubmed-article:3745962pubmed:meshHeadingpubmed-meshheading:3745962-...lld:pubmed
pubmed-article:3745962pubmed:year1986lld:pubmed
pubmed-article:3745962pubmed:articleTitleEffect of L-carnitine on cultured murine melanoma cells exposed to azelaic acid.lld:pubmed
pubmed-article:3745962pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3745962pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed